Features and Benefits
• Accurate and robust protein expression profiling against 112 p53 pathway-related antibodies.
• Establish protein expression profile comparisons of two samples (test vs. reference).
• Proprietary slide treatment minimizes background staining.
Other Notes
The p53 pathways antibody is designed for studying protein expression in cell or tissue extracts. The array contains 112 different antibodies spotted in duplicate on a nitrocellulose-coated glass slide. The antibodies are specific for proteins known to be involved in p53 pathways.
Please note that featured antibody content is lot specific and is subject to change.
Legal Information
Benzonase® Nuclease is manufactured by Merck KGaA and its affiliates. The technology is covered by US Patent 5,173,418 and EP Patent 0,229,866. Nycomed Pharma A/S (Denmark) claims worldwide patent rights to Benzonase® Nuclease, which are licensed exclusively to Merck KGaA, Darmstadt, Germany. Benzonase® is a registered trademark of Merck KGaA, Darmstadt, Germany.
Cy is a trademark of Amersham Pharmacia Biotech, UK Ltd.
quadriPERM is a registered trademark of Heraeus Instrument GmbH.
TWEEN is a registered trademark of Uniqema, a business unit of ICI Americas Inc.
Panorama is a registered trademark of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co.